EVAR中喇叭形髂支并发症的解剖预测因素
这项回顾性比较分析纳入533例EVAR患者,比较标准髂支与喇叭形髂支的并发症。总体髂支并发症罕见,但CIA长度≤30 mm或直径≥20 mm是喇叭形髂支晚期并发症的独立预测因素,两者并存时风险进一步升高。
要点
- EVAR中髂支并发症总体罕见,标准支与喇叭形支5年通畅率无显著差异。
- CIA长度≤30 mm或直径≥20 mm显著增加喇叭形髂支晚期并发症风险。
- 两个解剖危险因素并存时,喇叭形髂支的无并发症生存率进一步降低。
核心结论
- EVAR中髂支并发症不常见,但CIA长度≤30 mm或直径≥20 mm显著增加喇叭形髂支晚期并发症风险,两者并存时风险更高。
研究设计与样本
- 回顾性比较分析纳入2012至2017年治疗的533例EVAR患者(平均年龄75岁,442例男性),共1066条髂支。
- 比较标准髂支组(n=808,CIA<16 mm)与喇叭形髂支组(n=258,CIA扩张)的并发症。
- 随访包括术后3、6、12个月及每年 duplex 超声,怀疑髂支并发症时行CTA;采用Cox回归和Kaplan-Meier分析。
主要发现
- 30天内无髂支并发症;平均随访38±8个月共10例(1%)事件(4例髂支闭塞,6例Ib型内漏),喇叭形支7例(3%),标准支3例(0.4%),p=0.20。
- 5年免于髂支闭塞率标准支99%±1% vs 喇叭形支98%±1%(p=0.30);免于Ib型内漏率96%±3% vs 97%±1%(p=0.44)。
- 5年总体髂支并发症率标准支96%±3% vs 喇叭形支95%±2%(p=0.21)。
- Cox回归显示CIA长度≤30 mm(HR 4.7,95%CI 1.02-21.6,p=0.04)和直径≥20 mm(HR 7.8,95%CI 1.05-64.8,p=0.03)是喇叭形支髂支并发症的独立预测因素。
- 喇叭形支中CIA长度≤30 mm时5年无并发症生存率79%±9% vs 98%±1%(p=0.003);直径≥20 mm时85%±7% vs 99%±1%(p=0.02);两者并存时67%±19% vs 一个或无危险因素96%±2% vs 99%±1%(p<0.001)。
关键数值与推荐
- 喇叭形髂支用于扩张的CIA,标准髂支用于CIA<16 mm者。
- CIA长度≤30 mm:HR 4.7(95%CI 1.02-21.6,p=0.04)。
- CIA直径≥20 mm:HR 7.8(95%CI 1.05-64.8,p=0.03)。
- 两个危险因素并存时5年无髂支并发症生存率67%±19%,显著低于一个或无危险因素者(96%±2% vs 99%±1%,p<0.001)。
临床怎么用
- EVAR术前应评估CIA长度和直径,对计划使用喇叭形髂支者尤其注意CIA≤30 mm或≥20 mm的情况。
- 存在上述解剖特征时,喇叭形髂支术后需加强影像随访以早期发现Ib型内漏或髂支闭塞。
- 两个危险因素并存时风险更高,可考虑个体化选择髂支策略并密切监测。
局限性
- 回顾性比较分析,非随机分组,可能存在选择偏倚。
- 髂支并发症事件数少(共10例),统计效能有限。
- 随访时间平均38±8个月,长期结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To evaluate possible predictors of complications with flared iliac stent-graft limbs for ectatic common iliac arteries (CIAs) associated with abdominal aortic aneurysms treated with endovascular aneurysm repair (EVAR). Materials and Methods: A retrospective comparative analysis was conducted of 533 EVAR patients (mean age 75 years; 442 men) treated between 2012 and 2017 who had complications associated with the stent-graft limbs (n=1066). Complications, including type Ib endoleak, type IIIa endoleak, and limb occlusion, were compared between patients with nondilated (<16 mm) CIAs treated with standard iliac limbs (SLs, n=808) vs patients with ectatic CIAs treated with flared limbs (FLs, n=258). Follow-up included a duplex scan at 3, 6, and 12 months and yearly thereafter; computed tomography angiography was performed in case of iliac complications. Risk factors for iliac complications in FLs were investigated using Cox regression and Kaplan-Meier analyses; results of the regression analysis are presented as the hazard ratio (HR) and 95% confidence interval (CI). Results: Overall, no iliac complications occurred at 30 days, but over a mean follow-up of 38±8 months, there were 10 (1%) events (4 limb occlusions, 6 type Ib endoleaks): 7 (3%) in FLs and 3 (0.4%) in SLs (p=0.20). Kaplan-Meier analysis found no differences at 5 years in SLs vs FLs for freedom from limb occlusion (99%±1% vs 98%±1%, respectively; p=0.30) or type Ib endoleak (96%±3% vs 97%±1%, respectively; p=0.44). Similarly, the overall 5-year iliac complication rates were similar in SLs vs FLs (96%±3% vs 95%±2%, p=0.21). Regression analysis found CIA length ≤30 mm (HR 4.7, 95% CI 1.02 to 21.6, p=0.04) and a diameter ≥20 mm (HR 7.8, 95% CI 1.05 to 64.8, p=0.03) to be independent predictors of iliac complications in FLs. Kaplan-Meier estimates of iliac complication-free survival in FLs were significantly worse when the CIA length was ≤30 mm (79%±9% vs 98%±1%, p=0.003) or the diameter was ≥20 mm (85%±7% vs 99%±1%, p=0.02). The combination of both risk factors produced significantly poorer iliac complication-free survival compared with cases in which there was one or no risk factor (67%±19% vs 96%±2% vs 99%±1%, respectively; p<0.001). Conclusion: Iliac limb complications are infrequent in EVAR, regardless of the type of iliac limb chosen; however, CIAs ≤30 mm in length or ≥20 mm in diameter significantly increased the risk of late iliac complications in FLs. If both characteristics were present, this risk was further elevated.
引用
- Pini R, Faggioli G, Indelicato G, et al. Anatomical Predictors of Flared Limb Complications in Endovascular Aneurysm Repair. J Endovasc Ther. 2019. PMID: 31140360. doi:10.1177/1526602819851251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。